Join date: Dec 30, 2021

The flow cytometry market is expected to register a CAGR of 8.1% to reach USD 6.3 Billion in 2026 from USD 4.3 Billion in 2021. The growth of the flow cytometry market is largely driven by rising global incidence and prevalence of HIV/AIDS and cancer, growing adoption of flow cytometry techniques in research and academia, growing public-private initiatives in the fields of immunology and immuno-oncology research, technological advancements, and the increasing incorporation of AI platforms in flow cytometry workflows and advancements in flow cytometry software. Flow Cytometry Market

More actions